You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 9,354,240


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,354,240
Title:Probe for analyzing biological tissue and method for utilizing same
Abstract: The present invention relates to a method for obtaining cells or cell populations having a high biological activity from a biological tissue by enzymatic isolation, and probes for use in the method; more specifically to a method for analyzing a biological tissue, comprising applying two or more probes respectively containing biological-component binding domains through which two or more proteins bind to a predetermined biological component, to an isolated biological tissue, and analyzing binding amounts of the probes to the biological tissue.
Inventor(s): Yamagata; Youhei (Miyagi, JP), Goto; Masafumi (Miyagi, JP), Watanabe; Kimiko (Miyagi, JP)
Assignee: TOHOKU UNIVERSITY (Miyagi, JP) MEIJI SEIKA PHARMA CO., LTD. (Tokyo, JP)
Application Number:14/003,495
Patent Claims:1. A method for separating cells or cell populations from a biological tissue, comprising: applying two or more probes respectively containing biological-component binding domains of two or more proteases and two or more visualization molecules to an isolated biological tissue, measuring binding amounts of the probes to the biological tissue through the visualization molecules, determining a quantitative ratio of the proteases based on results of the measurement, applying the proteases in the quantitative ratio to the biological tissue, and separating the cells or the cell populations from the biological tissue, wherein each of the proteases is selected from the group consisting of collagenase, trypsin, chymotrypsin, dispase, elastase, papain, pronase, thermolysin, subtilisin, bromelain, phytin, and thermitase, and wherein each of the two or more visualization molecules is a molecule that is different from the other two or more visualization molecules and that is selected from the group consisting of fluorescent molecules, luminescent molecules, and radioisotopes including a positron nuclide.

2. The method according to claim 1, wherein at least one of the two or more visualization molecules is a luciferase protein and/or fluorescent molecule selected from the group consisting of GFP, EGFP, YFP, BFP, CFP, DsRED, tdTomato, and RFP.

3. The method according to claim 2, wherein the luciferase protein has a peak wavelength and luminescent intensity different from a wild-type luciferase.

4. The method according to claim 2, wherein the luciferase protein is linked to a fluorescent molecule selected from the group consisting of GFP, EGFP, YFP, BFP, CFP, DsRED, tdTomato, and RFP via a linker.

5. The method according to claim 1, wherein each of the biological-component binding domains and the visualization molecules form a fusion protein.

6. The method according to claim 1, wherein each of the biological-component binding domains comprises a collagen binding domain of the proteases.

7. The method according to claim 6, wherein the collagen binding domains are collagen binding domains of collagenases selected from collagenases derived from the genus Clostridium.

8. The method according to claim 7, wherein the collagen binding domains are collagen binding domains of collagenase G and collagenase H derived from Clostridium histolyticum.

9. The method according to claim 1, comprising: applying the two or more probes separately to a biological tissue, and measuring binding amounts of the probes separately.

10. The method according to claim 1, comprising: applying the two or more probes simultaneously to a biological tissue, and measuring binding amounts of the probes simultaneously.

11. The method according to claim 1, wherein the probes each contain 1 to 20 repeats of a biological-component binding domain.

12. A method for separating cells or cell populations from a biological tissue, comprising: applying two or more probes respectively containing collagen binding domains of two or more collagenases and two or more visualization molecules to an isolated biological tissue, measuring binding amounts of the probes to the biological tissue through the visualization molecules, determining a quantitative ratio of the collagenases based on results of the measurement, applying the collagenases in the quantitative ratio to the biological tissue, and separating the cells or the cell populations from the biological tissue, wherein each of the two or more visualization molecules is a molecule that is different from the other two or more visualization molecules and that is selected from the group consisting of fluorescent molecules, luminescent molecules, and radioisotopes including a positron nuclide.

13. The method according to claim 12, wherein at least one of the two or more visualization molecules is a luciferase protein and/or fluorescent molecule selected from the group consisting of GFP, EGFP, YFP, BFP, CFP, DsRED, tdTomato, and RFP.

14. The method according to claim 12, wherein the collagen binding domains are collagen binding domains of collagenases selected from collagenases derived from the genus Clostridium.

15. The method according to claim 14, wherein the collagen binding domains are collagen binding domains of collagenase G and collagenase H derived from Clostridium histolyticum.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.